Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Agreement for Engebø rutile sales and participation in construction financing

Nordic Mining ASA ("Nordic Mining") has today signed a Heads of Agreement with a reputable Japanese trading house (the "Trading House") related to long term offtake for rutile and participation in the construction financing for the Engebø project. The Trading House has a longstanding international track-record and operates within a wide range of industries.The Heads of Agreement is based on the following main principles: · Offtake agreement The basic principles of an offtake agreement for a significant portion of the anticipated production of rutile at Engebø have been agreed. The

Camanio Care enters the Life Science Hotlist of Invest Stockholm

Invest Stockholm works with highlighting investment opportunities in the Stockholm-Uppsala region. Out of 95 screened companies, they have chosen Camanio Care as one of five new companies on their Life Science Hotlist, a list which will by this decision contain a total of 22 companies in Health Tech.Camanio Care has been identified by Invest Stockholm as one of the hottest investment opportunities within Life Science in the Stockholm-Uppsala region. It is first after a thorough screening and evaluation that companies are added to their Life Science Hotlist and in their judgement Camanio

UPM Financial Statements Release 2018: UPM delivered record earnings in 2018 - in a strong position for 2019

UPM-Kymmene Corporation      Financial Statements Release         31 January 2019 at 09:40 EET UPM Financial Statements Release 2018:UPM delivered record earnings in 2018 - in a strong position for 2019 Q4 2018 highlights · Sales grew by 6% to EUR 2,731 million (2,571 million in Q4 2017). · Comparable EBIT increased by 10% to EUR 404 million (366 million). · Sales prices increased in all business areas, outweighing the impact of higher input costs. · Operating cash flow was strong at EUR 420 million (407 million). · Net debt decreased to EUR -311 million (

Eyeonid Group AB (publ) has called for Tranche 3 from the European Select Growth Opportunities Fund, free warrants to existing shareholders

Eyeonid Group AB (“Eyeonid Group”) has called for a third tranche of SEK 10 million within the framework of the financing agreement with European Select Growth Opportunities Fund (the “Investor” or “ESGO”) announced in a press release on January 31, 2018. The transaction will take place through the issuance of convertible notes with related warrants (TO4). Eyeonid Group has now called upon SEK 50 million out of up to SEK 100 million of commitment from ESGO.In conjunction with the transaction, Eyeonid will also issue free identical warrants (TO4) to existing shareholders, to protect them

Announcement of change in the total number of votes in AB SKF

Gothenburg, 31 January 2019: Due to a conversion of shares from Series A to Series B in accordance with the Company’s Articles of Association, AB SKF confirms the following. As per 31 January the Company’s share capital amounts to SEK 1,138,377,670 and the total number of shares amounts to 33,221,095 shares of Series A and 422,129,973 shares of Series B. The number of votes in the Company amounts to 75,434,092. AB SKF does not hold any own shares. Aktiebolaget SKF     (publ) This is information that AB SKF is obliged to make public pursuant to the Financial Instruments Trading

Biotage AB – changes in number of shares and votes

As previously announced, Biotage AB (publ) (Biotage) has during January 2019 issued 487,337 new shares in connection with the acquisition of PhyNexus, Inc. Prior to the issue, the total number of outstanding shares and votes in Biotage was 64,714,447. Through the issue the number of shares in Biotage increased by 487,337, corresponding to 487,337 votes. Today, the last trading day of the month, the total number of shares and votes in Biotage is 65,201,784. This is information that Biotage AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act.

New number of shares and votes in Swedish Orphan Biovitrum AB (publ)

New number of shares and votes in Swedish Orphan Biovitrum AB (publ) As per 31 January 2019, the total number of shares in Swedish Orphan Biovitrum AB (publ)  (Sobi™) amounts to 297,515,209 shares. All shares are common shares. The total number of votes is 297,515,209. The increase in the number of shares and votes results from an issue of 24,193,092 common shares. The common shares have been issued in connection with the acquisition from AstraZeneca of rights to Synagis® (palivizumab) in the US. As per 31 January 2019 the company holds 3,423,726 common shares. --

Nordea's Fourth Quarter and Full Year Results 2018 will be presented on Wednesday 6 February 2019

The report will be published at approximately 07.30 EET (06.30 CET). Conference call for media, investors and equity analysts Time: 09.00 EET (08.00 CET). Casper von Koskull, President and Group CEO, will present the results. To participate in the conference call (starting at 09.00 EET) and participate in the following Q&A session (starting at approximately 09.30 EET) with Casper von Koskull, President and Group CEO, Christopher Rees, Group CFO and Rodney Alfvén, Head of Investor Relations, please use the webcast link  or

Change in number of shares outstanding in Sectra during January

Press release – Linköping, Sweden, January 31, 2019 – During January, the number of shares outstanding in Sectra AB  (publ) (STO: SECT B) increased by 233,202 ordinary Class B shares. As of January 31, 2019, the number of shares totals 38,352,871.The change was attributable to a new share issue in connection with the conversion of Sectra’s convertible debenture program 2014/2018  and 2015/2018 .

Hansa Medical to Host Conference Call to Provide Year-End Report 2018 Business Update

Lund, Sweden, January 31, 2019 – Hansa Medical AB (publ) (Nasdaq Stockholm: HNSA) (“Hansa Medical” or the “Company”), under name change to Hansa Biopharma AB, a biopharmaceutical company focused on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, today announced that Hansa Medical will publish the 2018 Year-End Report on 8 February 2010, at 08:00AM CET, and that all interested parties are invited to participate in a telephone conference, which will include a presentation, on the same day at 2:00PM CET. The event will be hosted by Hansa Medical’s CEO and President, Søren

Elisa's Board of Directors has approved a new share-based incentive plan for key personnel

LISA CORPORATION STOCK EXCHANGE RELEASE 31 JANUARY 2019 AT 9:15 AM The aim of the new Restricted Share Plan 2019 is to align the objectives of the shareholders and key employees in order to increase the value of the company in the long-term, and to retain key employees at the company, and to offer them a competitive reward plan that is based on receiving the company’s shares. The Restricted Share Plan is directed only to selected key employees in the Elisa. The vesting periods will last for 12 to 36 months. The prerequisite for reward payment is that a key employee’s employment or

NPRO: INVITATION TO PRESENTATION OF FOURTH QUARTER AND FULL YEAR 2018

Norwegian Property ASA (OSE: NPRO, NPRO.OL) releases its fourth quarter and full year results for 2018 on Thursday 7 February 2019, and we are pleased to invite investors, analysts and media to a presentation of the results. The presentation will be in Norwegian only, and it will be held by Bent Oustad (CEO) and Haavard Rønning (CFO).  Date: Thursday 7 February 2018Time: 08:30 a.m. Central European TimeLocation: 5th floor in Kaibygg I, entrance from Bryggegata 6 at Aker Brygge in Oslo, Norway. The presentation will also be broadcasted live via webcast. The webcast may be followed

Proposal of the Shareholders’ Nomination Board for the composition and remuneration of Tokmanni’s Board of Directors

Tokmanni Group Corporation         Stock exchange release                     31 January 2019 at 9:00 amThe Shareholders’ Nomination Board of Tokmanni Group Corporation proposes to the Annual General Meeting that the number of the members of the Board of Directors remain the same and will be six (6). The Nomination Board proposes that the current members of the Board of Directors Juha Blomster, Therese Cedercreutz, Kati Hagros, Erkki Järvinen, Seppo Saastamoinen and Harri Sivula will be re-elected until the end of the next Annual General Meeting. All proposed persons have granted

Attendo's year-end report for 2018 to be published on 14 February - Invitation to teleconference

On 14 February, around 08:00 am (CET), Attendo will present its year-end report and fourth quarter result for 2018. Investors, analysts and journalists are hereby invited to participate in a teleconference at 10:00 am (CET) on the same date.The teleconference will be hosted by Attendo’s CEO Martin Tivéus and CFO Fredrik Lagercrantz. The presentation will be held in English. Date:             14 February 2019Time:             10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the start of the call: SE:                +46

Increased number of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 56,308,872 following a directed share issue of a total of 22,000 shares.The company has resolved on a directed issue of a total of 22,000 shares by virtue of the company’s incentive program. The share issue has been registered with Maltese authorities in January 2019. Subsequent to the share issue, the number of shares and votes in Catena Media has increased from 56,286,872 to 56,308,872 and the share capital has increased to EUR 84,463. For further information, please contact:    Per Hellberg, CEO, Catena Media plc

Increase of number of votes in Hansa Medical AB (publ)

Lund, Sweden, January 31, 2019 – Hansa Medical AB (publ) (Nasdaq Stockholm: HNSA) (“Hansa Medical” or the “Company”), under name change to Hansa Biopharma AB, a biopharmaceutical company focused on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, today announced that the Company’s number of votes has changed as a result of the conversion of 13,142 C shares into ordinary shares during January under Hansa Medical’s long-term incentive program.As of January 31, 2019, the total number of registered and outstanding shares of Hansa Medical totals 40,681,654 of which 39,973,032 are

Invitation to presentation of ICA Gruppen’s year-end report 2018

ICA Gruppen will publish its year-end report on Thursday, 7 February 2019. In conjunction to this, we are pleased to issue this invitation to a press and analyst meeting.Place: IVA Grev Turegatan 16, Stockholm Time: Thursday, 7 February at 10.00 CET ICA Gruppen’s CEO Per Strömberg and CFO Sven Lindskog will present the year-end report and answer any subsequent questions. The press and analyst meeting will be available as a live webcast and can be viewed at http://www.icagruppen.se/en/investors To attend the telephone conference: SE: +46850558352 UK: +443333009030 A

The Nomination Committee’s proposal for Telia Company’s Annual General Meeting

The Nomination Committee today presents its proposal to Telia Company’s Annual General Meeting on April 10, 2019 regarding the election of members of the Board of Directors and Chair of the Board. The proposal will also be presented in the Annual General Meeting notice.Telia Company’s Nomination Committee was established after a decision at the 2018 Annual General Meeting and consists of Daniel Kristiansson, Chair (Swedish state), Erik Durhan (Nordea Fonder), Jan Andersson (Swedbank Robur Fonder), Anders Oscarsson (AMF and AMF Fonder) and Marie Ehrling (Chair of the Board). The

Nomination Committee for Ripasso Energy appointed

The Nomination Committee for the Annual General Meeting 2019 in Ripasso Energy AB has been appointedIn accordance with the instructions for the Nomination Committee adopted at the Annual General Meeting 2018 in the company, the Nomination Committee shall consist of representatives of the three largest registered shareholders in the share register maintained by Euroclear Sweden AB as of the last banking day in August each year. The Chairman of the Board shall convene the Nomination Committee to its first meeting. The third largest shareholder shall be appointed as Chairman of the Nomination

Nel ASA: Key information relating to subsequent offering to be carried out by Nel ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANYOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Nel ASA: Key information relating to subsequent offering to be carried out by Nel ASA (Oslo, 31 January 2019) Reference is made to the stock exchange notice from Nel ASA (the "Company") on 30

Nordic Nanovector ASA – allocation of PSUs

Oslo, Norway, 31 January 2019 The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 31 January 2019 decided to grant 259,000 Performance Share Units ("PSUs") to employees in accordance with the authorisation granted at the Annual General Meeting held on 30 May 2018 (the "AGM"). The terms and conditions of the PSUs, which are part of the Company's long-term incentive plan for employees, are described on pages 16-23 in the Company's annual report for 2017. The PSUs are granted without consideration. The PSUs are non-transferable and will vest

AcadeMedia’s interim report July – December 2018

AcadeMedia’s interim report July – December 2018  Second quarter (October – December 2018) · Net sales increased by 9.3 percent and amounted to SEK 3,076 million (2,813). Organic growth, including bolt-on acquisitions, was 4.5 percent. · Operating profit (EBIT) decreased by 22.9 percent to SEK 128 million (166). The decline was related to the Adult Education segment, but is partially offset by the strong development in the Upper Secondary School segment. Adjusted for items affecting comparability, operating profit was SEK 139 million (167). · Net profit for the period was SEK

Proposal of the Shareholders' Nomination Board on the composition and remuneration of the Board of Directors of Finnair Plc

Finnair Plc         Stock Exchange Release           31 January 2019 at 9.00 am EET The Shareholders' Nomination Board proposes to Finnair Plc's Annual General Meeting (AGM) to be held on 20 March 2019 that the number of members of the Board of Directors would be confirmed as eight. Proposal on the composition of Board of Directors The Shareholders' Nomination Board proposes that Colm Barrington, Montie Brewer, Mengmeng Du, Jouko Karvinen, Henrik Kjellberg and Jaana Tuominen be re-elected as members of the Board of Directors, and that Tiina Alahuhta-Kasko and Jukka Erlund be

H & M Hennes & Mauritz AB Full-year report

Full-year (1 December 2017 – 30 November 2018) · The H&M group’s net sales, increased by 5 percent to SEK 210,400 m (200,004) in the financial year. In local currencies, net sales increased by 3 percent. The ongoing transition work contributed to gradually improved sales development and increased market share in most markets during the second half. · The group’s online sales continued to develop very well during the year. Online sales amounted to approximately SEK 30 billion, an increase of 22 percent, thereby making up for 14.5 percent (12.5) of the group’s total sales. In local

There are no items matching the current filter
There are no more items matching the current filter
Back to top